News

Drug Store News16h
Aurobindo, Cipla and Viatris to make long acting injectable for HIV treatment
Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir. Aurobindo, Cipla and ...
GSK signs US$12.5 billion licence deal with Hengrui as China rises in global pharmaceuticals
The deal would give GSK the rights to develop the drug for HRS-9821 and 11 preclinical programmes owned by Jiangsu Hengrui ...
Renal Cancer Pipeline Outlook Report 2025: Key 75+ Companies And Breakthrough Therapies Shaping The Future Landscape
In July 2025, Bristol-Myers Squibb announced a study is to assess the safety and efficacy of nivolumab combined with ...
Hemophilia A Pipeline Outlook Report 2025: Key 40+ Companies And Breakthrough Therapies Shaping The Future Landscape
In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...
Contract Pharma44m
Boehringer Ingelheim, Re-Vana Therapeutics Partner on Long-Acting Ophthalmics
Boehringer Ingelheim and Re-Vana Therapeutics, a U.S. and UK based developer of ocular therapeutics and drug delivery ...
Biologic Therapeutics Market to Hit $794.5 Billion by 2029
According to the latest study from BCC Research, "Biologic Therapeutic Drugs: Technologies and Global Markets" is projected ...
BCC Research LLC: Biologic Therapeutics Market to Hit $794.5 Billion by 2029
"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative Vaccines" BOSTON ...